EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
EKG tracks a market cap-weighted index of globally-listed companies engaged in digital health technologies.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 4.4 M
ASSETS UNDER MGMT
65 bp
EXPENSES
Fund Basics
| Inception date | Mar 22, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| VEEVA SYSTEMS INC-CLASS A | 9.9 % |
| IQVIA HOLDINGS INC | 9.8 % |
| DEXCOM INC | 7.8 % |
| RESMED INC | 5.8 % |
| GUARDANT HEALTH, INC. | 5.6 % |
| ILLUMINA INC | 5.3 % |
| NATERA INC | 5.2 % |
| INTUITIVE SURGICAL INC | 4.8 % |
| OSCAR HEALTH, INC. CLASS A | 4.0 % |
| TEMPUS AI INC | 3.5 % |
Constituent Breakdown
| Number of holdings | 39 |
| Herfindahl-Hirschman Index | 478 |
| Wgt avg mkt cap (mns) | $23,821 |
| Large cap (>$10bn) | 61.5% |
| Mid cap ($2-10bn) | 33.8% |
| Small cap (<$2bn) | 4.6% |
| Developed mkts. | 98.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.0 % |
 |
NETHERLANDS | 2.9 % |
 |
COSTA RICA | 1.1 % |
Historical Performance
Standardized Performance (as of 08/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 16.3% | 27.0% | 14.8% | 11.0% | -- | -- | -- | 2.5% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | 16.3% | 27.0% | 14.8% | 11.0% | -- | -- | -- | 2.5% | Ann. Volatility | 26.2% | 23.5% | 24.7% | 24.4% | -- | -- | -- | 27.2% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.92 | 25% |
| MSCI EAFE | 0.62 | 17% |
| MSCI Emg Mkts | 0.28 | 8% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 1.0% |
| Avg. Bid/Ask (% of price) | 0.27% |
Technical Indicators
| 30d moving avg. (EMA) | $19.81 |
| Relative strength (RSI) | 65 |
| MACD/Signal | 0.61/0.49 |
| Bollinger Bands (Upper/Lower) | $21.67/$18.08 |
| Short interest (% of AUM) | 3.7% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. EKG |
Expenses vs. EKG |
ALTAR Score™ vs. EKG |
|---|---|---|---|---|
| HEAL | Global X HealthTech ETF | 49.0% | -15 bp | -1.5% |
| HLTH | Tema Healthcare AI ETF | 32.3% | +10 bp | -0.3% |
| GNOM | Global X Genomics & Biotechnology ETF | 25.1% | -15 bp | -3.2% |
| FDHT | Fidelity Digital Health ETF | 23.1% | -26 bp | +1.5% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 22.9% | +3 bp | +1.0% |
| FMED | Fidelity Disruptive Medicine ETF | 21.4% | -15 bp | -1.9% |
| GNMX | Corgi Genomics & Precision Medicine ETF | 21.1% | -30 bp | -3.9% |
| ARKG | ARK Genomic Revolution ETF | 20.7% | +10 bp | -2.7% |
| HELX | Franklin Genomic Advancements ETF | 19.0% | -15 bp | -1.8% |
| IHI | iShares U.S. Medical Devices ETF | 18.8% | -25 bp | +4.4% |
Risk and Returns: EKG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 9/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
0.8%
ALTAR SCORE™
9th
PERCENTILE
AVOID
ETFRC RATING
There are 734 funds in the Global Equity category with an average
ALTAR Score™ of 4.3% and a standard deviation
of 2.6%. EKG's ALTAR Score™ is approximately -1.4 standard
deviations above the category average. This places EKG in the 9th percentile
among funds in the category.
Sell-Side Consensus
$22.61
PRICE TARGET
+3.2%
UPSIDE